Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06219538 · ClinicalTrials.gov registry record · NA
DAISY Uterine Drain Device Evaluation
A NA study, sponsored by Raydiant Oximetry.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT06219538: Completed NA study, sponsored by Raydiant Oximetry.
NCT06219538 is a NA study that has completed, run by Raydiant Oximetry. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06219538, a NA study, has completed, sponsored by Raydiant Oximetry.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this study is to obtain user feedback while placing and observing the DAISY uterine drain with wall suction. This study defines the obstetrical surgeons as "users" and the patients in whom the drain is placed as "participants." Participants are pregnant women who are undergoing cesarean delivery (CD), who have not entered active labor, who have consented to drain placement and who have met all the inclusion/exclusion criteria. Users are staff or fellow obstetrical surgeons who will use the drain and provide the evaluation.
Interventions
- DEVICE DAISY Uterine Drain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2025-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06219538
The ClinicalTrials.gov registry entry for NCT06219538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Raydiant Oximetry, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DAISY Uterine Drain is the first listed.
NCT06219538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06219538 about?
NCT06219538 is a clinical study titled "DAISY Uterine Drain Device Evaluation". The goal of this study is to obtain user feedback while placing and observing the DAISY uterine drain with wall suction. This study defines the obstetrical surgeons as "users" and the patients in whom the drain is placed as "participants." Participants are pregnant women who are undergoing cesarean ...
What is the current status of trial NCT06219538?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-05-22. Estimated completion is 2025-04-16.
What interventions are being tested in trial NCT06219538?
The interventions under investigation include: DAISY Uterine Drain (DEVICE).
Who is sponsoring clinical trial NCT06219538?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.